Evidence map›Paper›PMID 34040653›Full record

ReviewEuropean cardiology2021

The Association Between Psoriasis and Cardiovascular Diseases.

Ahmed Zwain, Mohanad Aldiwani, Hussein Taqi

Abstract readReview
In one paragraph

Review in European cardiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. The Emerging Specialty of Cardio-Rheumatology.Current atherosclerosis reports · 2024
    Review
  9. Pivotal Role of mTOR in Non-Skin Manifestations of Psoriasis.International journal of molecular sciences · 2024
    Review
  10. Zinc, Copper, and Iron in Selected Skin Diseases.International journal of molecular sciences · 2024
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ahmed ZwainNorth West Deanery, Aintree University Hospital Liverpool, UK.
Mohanad AldiwaniEast Midlands Deanery, University Hospitals of Leicester NHS Trust Leicester, UK.
Hussein TaqiEast Midlands Deanery, Royal Derby Hospital Derby, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular diseases and psoriasis have been well established as separate entities, however, there is uncertainty with regards to a link between the two diseases. A few environmental, psychological and social factors have been implicated as potential common risk factors that may exacerbate the two diseases, and an array of complex immune and non-immune inflammatory mediators can potentially explain a plausible link. Pharmacotherapy has also played a role in establishing a potential association, especially with the advent of biological agents which directly act on inflammatory factors shared by the two diseases. This review will look at existing evidence and ascertain a potential correlation between the two.

Indexed as

atherosclerosiscardiovascular riskcytokineshyperlipidaemiainflammationischaemic heart diseaseMIpathophysiologyPsoriasispsoriasis vulgarisvascular disease

Identifiers

PMID34040653
PMCPMC8145074

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.